Despite major advances in care, nearly half of U.S. adults live with some form of cardiovascular disease or stroke, according to the American Heart Association(R), a relentless force changing the ...

Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, has been named a winner in ...

The hospital has continued to see growth in scans at multiple locations – meaning it is holistically seeing more patients who ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...

The American College of Cardiology has partnered with OpenEvidence to speed up the translation of research into clinical implementation.  Through the strategic partnership, OpenEvidence users will ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

New study has discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad ...

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers ...

New research reveals how gut microbes may influence the development of coronary artery disease, the world’s leading killer.

Amgen's Repatha cholesterol drug significantly reduces the risk of first cardiac events by 25% in at-risk patients.

Routine eye exams can reveal early signs of heart disease. Understand why eye screenings are considered valuable for early ...

Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...